Genetic variations in 3'UTRs of SMUG1 and NEIL2 genes modulate breast cancer risk, survival and therapy response.

导出 LinkOut

翻译打印收藏纠错

作者： Andrea,Cumova ^[1] ; Veronika,Vymetalkova ^[2] ; Alena,Opattova ^[1] ; Veronika,Bouskova ^[2] ; Barbara,Pardini ^[3] ; Katerina,Kopeckova ^[1] ; Renata,Kozevnikovova ^[2] ; Katerina,Lickova ^[3] ; Miloslav,Ambrus ^[3] ; Ludmila,Vodickova ^[4] ; Alessio,Naccarati ^[5] ; Pavel,Soucek ^[6] ; Pavel,Vodicka ^[7]

作者单位： Department of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, 14200, Czech Republic. ^[1] Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, 12800, Czech Republic. ^[2] Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, 306 05, Czech Republic. ^[3] IIGM Italian Institute for Genomic Medicine, Candiolo, 10060, Italy. ^[4] Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060, Italy. ^[5] Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, 15006, Czech Republic. ^[6] Onkocentrum, MEDICON Services s.r.o., Prague, 14000, Czech Republic. ^[7] Radiotherapy and Oncology Department, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, 10034, Czech Republic. ^[8] Toxicogenomics Unit, National Institute of Public Health, Prague, 10000, Czech Republic. ^[9]